ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
65.36
+0.41 (0.63%)
Apr 26, 2024, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 221.12 | 53.23 | 100.3 | 12.87 | 67.36 | 48.03 | 36.15 | 32.37 | 154.68 | 169.04 | Upgrade
|
| Cash & Cash Equivalents | 221.12 | 53.23 | 100.3 | 12.87 | 67.36 | 48.03 | 36.15 | 32.37 | 154.68 | 169.04 | Upgrade
|
| Cash Growth | 315.38% | -46.93% | 679.51% | -80.90% | 40.25% | 32.86% | 11.69% | -79.08% | -8.49% | 1422.17% | Upgrade
|
| Receivables | 162.08 | 165.44 | 128.53 | 95.79 | 72.13 | 64.84 | 58.79 | 45.9 | 21.93 | 17.3 | Upgrade
|
| Inventory | 111.2 | 105.36 | 81.69 | 60.8 | 48.16 | 40.5 | 37.73 | 26.18 | 13.39 | 7.52 | Upgrade
|
| Other Current Assets | 25.42 | 20.23 | 11.26 | 0.86 | 0.04 | -0.5 | -1.06 | -1.44 | 2.58 | 1.14 | Upgrade
|
| Total Current Assets | 519.82 | 344.26 | 321.78 | 170.32 | 187.7 | 152.88 | 131.61 | 103.01 | 192.58 | 194.99 | Upgrade
|
| Property, Plant & Equipment | 44.59 | 43.25 | 52.67 | 41.27 | 40.55 | 38.09 | 20.4 | 11 | 7.13 | 5.22 | Upgrade
|
| Long-Term Investments | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Goodwill and Intangibles | 237.23 | 279.86 | 322.01 | 192.09 | 183.97 | 205.18 | 231.63 | 177.63 | 68.24 | 43.91 | Upgrade
|
| Other Long-Term Assets | 102.78 | 92.72 | 70.14 | 57.51 | 44.58 | 34.45 | 28.5 | 31.23 | 17.32 | 15.44 | Upgrade
|
| Total Long-Term Assets | 384.61 | 415.83 | 449.82 | 290.87 | 269.09 | 277.73 | 280.53 | 219.86 | 92.68 | 64.57 | Upgrade
|
| Total Assets | 904.42 | 760.09 | 771.6 | 461.19 | 456.79 | 430.6 | 412.14 | 322.86 | 285.27 | 259.56 | Upgrade
|
| Accounts Payable | 36.68 | 29.31 | 22.97 | 11.26 | 14.61 | 8.88 | 3.63 | 3.39 | 2.07 | 2.65 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0.08 | 0.45 | 0.71 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 0.85 | 0.85 | 0.85 | 13.24 | 9.94 | 115.72 | 3.35 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 107.94 | 69.28 | 63.72 | 53.98 | 36.68 | 40.24 | 32.25 | 28.56 | 9.69 | 10.58 | Upgrade
|
| Total Current Liabilities | 145.48 | 99.44 | 87.54 | 78.57 | 61.68 | 165.55 | 39.23 | 31.95 | 11.76 | 13.23 | Upgrade
|
| Long-Term Debt | 284.82 | 285.67 | 286.52 | 172.44 | 175.81 | 67.3 | 198.15 | 120.64 | 113.43 | 106.54 | Upgrade
|
| Other Long-Term Liabilities | 16.53 | 36.44 | 38.8 | 14.48 | 6.51 | 0.5 | 0 | 0.63 | 0 | 0 | Upgrade
|
| Total Long-Term Liabilities | 301.35 | 322.11 | 325.32 | 186.93 | 182.32 | 67.79 | 198.15 | 121.27 | 113.43 | 106.54 | Upgrade
|
| Total Liabilities | 446.82 | 421.55 | 412.86 | 265.49 | 244 | 233.34 | 237.38 | 153.22 | 125.18 | 119.77 | Upgrade
|
| Total Debt | 285.67 | 286.52 | 287.37 | 185.69 | 185.75 | 183.02 | 201.51 | 120.64 | 113.43 | 106.54 | Upgrade
|
| Debt Growth | -0.30% | -0.30% | 54.76% | -0.03% | 1.49% | -9.18% | 67.03% | 6.36% | 6.46% | - | Upgrade
|
| Retained Earnings | -80.13 | -97.29 | -47.77 | -4.97 | 17.58 | 11.49 | -4.01 | -2.92 | -4.35 | -19.73 | Upgrade
|
| Comprehensive Income | 8.86 | 12.17 | -3.06 | -11.44 | -4.87 | -0.38 | 0 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | 432.75 | 313.69 | 333.89 | 195.7 | 212.79 | 197.26 | 174.76 | 169.65 | 160.08 | 139.79 | Upgrade
|
| Net Cash / Debt | -64.55 | -233.29 | -187.07 | -172.82 | -118.39 | -134.99 | -165.36 | -88.28 | 41.26 | 62.5 | Upgrade
|
| Net Cash / Debt Growth | - | - | - | - | - | - | - | - | -33.99% | 462.78% | Upgrade
|
| Net Cash Per Share | -3.55 | -14.35 | -14.85 | -14.44 | -9.83 | -11.47 | -14.32 | -7.63 | 3.57 | 5.65 | Upgrade
|
| Working Capital | 374.34 | 244.82 | 234.24 | 91.76 | 126.02 | -12.67 | 92.38 | 71.06 | 180.83 | 181.76 | Upgrade
|
| Book Value Per Share | 23.79 | 19.29 | 26.51 | 16.36 | 17.67 | 16.76 | 15.13 | 14.66 | 13.85 | 12.65 | Upgrade
|